Carboplatin
Links shared publicly online about this topic
Oncology Article | Carboplatin Ovarian Neoplasms
mdlinx.com — “Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: The Mito-2 Randomized Phase III Trial” View full resource at mdlinx.com
Most Recently Shared on August 18, 2011 at 6:19 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line trea... http://t.co/gQvyhct #oncology
Oncology Article | Carboplatin Radiotherapy Seminoma
mdlinx.com — “Randomized trial of carboplatin versus radiotherapy for stage I seminoma” View full resource at mdlinx.com
Most Recently Shared on February 8, 2011 at 5:40 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Randomized trial of carboplatin versus radiotherapy for stage I seminoma: Journal of Clinical Oncology http://bit.ly/gTl8gc #oncology
Oncology Article | Carboplatin Ovarian Neoplasms
mdlinx.com — “Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients” View full resource at mdlinx.com
Most Recently Shared on June 2, 2011 at 6:04 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian ... http://bit.ly/jccmI8 #oncology
Urology Article | Carboplatin Prostatic Neoplasms
mdlinx.com — “Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer” View full resource at mdlinx.com
Most Recently Shared on July 18, 2011 at 9:46 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combin... http://bit.ly/p3o1Bz #urology
Oncology Article | Carboplatin Prostatic Neoplasms
mdlinx.com — “Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer” View full resource at mdlinx.com
Most Recently Shared on June 29, 2011 at 7:28 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combi... http://bit.ly/mO87P5 #oncology
Oncology Medical News about Melanoma Paclitaxel Carboplatin
mdlinx.com — “A study of paclitaxel, carboplatin, and bortezomib in the treatment of metastatic malignant melanoma” View full resource at mdlinx.com
Most Recently Shared on May 4, 2010 at 5:50 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
A study of paclitaxel, carboplatin, and bortezomib in the treatment of metastatic malignant melanoma: Cancer http://bit.ly/9rUkmz #oncology
Oncology Article | Camptothecin Ovarian Neoplasms Carboplatin
mdlinx.com — “Phase II study of belotecan, a camptothecin analogue, in combination with carboplatin for the treatment of recurrent ovarian cancer” View full resource at mdlinx.com
Most Recently Shared on December 7, 2010 at 9:14 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase II study of belotecan, a camptothecin analogue, in combination with carboplatin for the treatmen... http://bit.ly/dJ8a4s #oncology
Oncology Medical News about Breast Neoplasms Carboplatin
mdlinx.com — “Differential response of triple-negative breast cancer to a docetaxel and carboplatin-based neoadjuvant treatment” View full resource at mdlinx.com
Most Recently Shared on June 21, 2010 at 6:26 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Differential response of triple-negative breast cancer to a docetaxel and carboplatin-based neoadjuvant t... http://bit.ly/aWrk6B #oncology
Oncology Article | Carboplatin Ovarian Neoplasms Paclitaxel
mdlinx.com — “Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer” View full resource at mdlinx.com
Most Recently Shared on January 31, 2011 at 6:17 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-r... http://bit.ly/eDTbxA #oncology
Oncology Article | Carboplatin Ovarian Neoplasms Paclitaxel
mdlinx.com — “Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/ refractory epithelial ovarian cancer” View full resource at mdlinx.com
Most Recently Shared on July 13, 2011 at 7:49 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery o... http://bit.ly/qLdG64 #oncology
Ob/Gyn Article | Carboplatin Ovarian Neoplasms
mdlinx.com — “Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients” View full resource at mdlinx.com
Most Recently Shared on June 2, 2011 at 7:15 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian can... http://bit.ly/kRnSI9 #OBGYN
Neurology Medical News about Carboplatin Tamoxifen Topotecan
mdlinx.com — “Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors” View full resource at mdlinx.com
Most Recently Shared on February 4, 2010 at 9:27 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Neuro: Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and car http://url4.eu/1JX8D
Oncology Medical News about Carboplatin Tamoxifen Topotecan
mdlinx.com — “Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors” View full resource at mdlinx.com
Most Recently Shared on February 9, 2010 at 11:40 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Oncology Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, ... http://bit.ly/bWKiDD
For The Treatment Of Ovarian Cancer, Pegylated Liposomal Doxorubicin/Carboplatin Will Replace Paclitaxel/Carboplatin
medicalnewstoday.com — “Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard o” View full resource at medicalnewstoday.com
Most Recently Shared on December 9, 2010 at 3:37 pm By:
For The Treatment Of Ovarian Cancer, Pegylated Liposomal Doxorubicin/Carboplatin Will Replace Paclitaxel/Carboplatin De.. http://dld.bz/AcP7
PLD/carboplatin to replace paclitaxel/carboplatin as gold-standard treatment for platinum-sensitive ovarian cancer
news-medical.net — “Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard of care for first- and second-line treatment of platinum-sensitive ovarian cancer, pegylated liposomal doxorubicin (PLD)/carboplatin will replace paclitaxel/carboplatin as the standard second-line treatment for patients who remain platinum sensitive.” View full resource at news-medical.net
Most Recently Shared on December 10, 2010 at 3:43 pm By:
Ovarian Cancer News: PLD/carboplatin to replace paclitaxel/carboplatin as gold-standard treatment for platinum-s... http://bit.ly/gI3hGR
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
